Get more information on Neurorehabilitation Market - Request Sample Report
The Neurorehabilitation Market was valued at USD 1.95 billion in 2023 and is expected to reach USD 6.18 billion by 2032, growing at a CAGR of 13.68% over the forecast period 2024-2032.
The neurorehabilitation market is experiencing rapid growth, fueled by the increasing prevalence of neurological disorders and the adoption of advanced therapeutic technologies. For instance, according to the World Health Organization (WHO), globally, 15 million people suffer a stroke annually, with nearly 5 million left permanently disabled, underscoring the critical need for effective rehabilitation solutions. Similarly, traumatic brain injuries affect approximately 69 million individuals each year, further driving demand for neurorehabilitation services.
Technological advancements have revolutionized the field of neurorehabilitation. For instance, virtual reality (VR)-based interventions have shown significant promise in motor function recovery. For Instance, A study published in the Journal of NeuroEngineering and Rehabilitation demonstrated that VR-based therapy improved upper limb motor function in 65% of post-stroke patients compared to conventional methods. Additionally, robotic-assisted therapy devices such as exoskeletons are increasingly utilized to facilitate repetitive motion exercises, which are crucial for motor recovery. For example, devices like the EksoNR and Lokomat have been widely adopted in rehabilitation centers, demonstrating improved patient outcomes.
Artificial intelligence (AI) is another transformative factor in this market. AI algorithms are being employed to design personalized treatment plans based on patient data, enhancing recovery efficiency. For example, AI-driven tools have successfully predicted patient recovery trajectories in stroke rehabilitation, allowing for optimized therapy sessions. Despite these advancements, challenges persist. Rehabilitation services are often expensive, with advanced robotic systems costing upwards of USD 100,000, limiting their accessibility in low-income regions. Moreover, a study cited by the American Heart Association revealed that only 30% of stroke patients in developing countries receive adequate rehabilitation.
Drivers
Advanced Neurotechnologies Driving Recovery
The integration of advanced neurotechnologies, such as brain-computer interfaces (BCIs) and non-invasive neurostimulation techniques like transcranial magnetic stimulation (TMS), is transforming the neurorehabilitation landscape. These technologies are crucial in enhancing neuroplasticity, which is the brain's ability to reorganize itself by forming new neural connections. This process is particularly beneficial for patients recovering from strokes, spinal cord injuries, or other neurological conditions. By promoting the brain's natural ability to heal and adapt, these technologies are leading to better recovery outcomes, reducing long-term disabilities, and accelerating rehabilitation timelines. The increasing adoption of these cutting-edge treatments is significantly driving the growth of the neurorehabilitation market.
Rise of Outpatient and Home-Based Therapies
Another major driver of growth in the neurorehabilitation market is the shift toward outpatient and home-based therapy options. With healthcare systems worldwide focusing on improving patient access and reducing costs, these alternatives are gaining significant traction. Home-based therapies offer patients the convenience of receiving treatment in the comfort of their own homes, without the need for frequent hospital visits. This not only enhances patient comfort but also promotes better adherence to rehabilitation programs. Additionally, outpatient services are making rehabilitation more accessible to populations in both developed and emerging markets. As a result, this trend is expanding the reach of neurorehabilitation services, particularly for those who may not have easy access to traditional inpatient rehabilitation centers.
Restraints
Challenges Hindering Growth in the Neurorehabilitation Market including High Costs, Limited Access, and Lack of Expertise
High costs associated with advanced technologies like robotic-assisted systems, brain-computer interfaces, and virtual reality platforms are a primary restraint. With devices costing over USD 100,000, many smaller healthcare facilities, particularly in low-income regions, cannot afford these innovations, limiting accessibility and adoption. Additionally, the shortage of skilled professionals, such as neurologists and therapists trained to use these complex systems, further hampers the market's growth. In developing countries, the lack of such expertise exacerbates the issue, delaying the widespread implementation of advanced neurorehabilitation therapies. Limited awareness of these technologies among patients and caregivers also plays a crucial role in slowing adoption. Cultural preferences for traditional methods and a lack of knowledge about the benefits of modern therapies hinder patients from seeking advanced treatments. Furthermore, the absence of standardized protocols and regulations creates uncertainty for healthcare providers and manufacturers, delaying the introduction of new technologies. Finally, inadequate insurance coverage and reimbursement policies make it difficult for many patients to access cutting-edge treatments, especially in economically disadvantaged areas, deepening healthcare access disparities. These factors combined pose significant challenges to the neurorehabilitation market's growth.
By Type
Neuro-robotic devices were the dominant segment in the neurorehabilitation market in 2023. These devices integrate robotics with neurorehabilitation therapies, enhancing patient recovery by facilitating repetitive movement, which promotes neuroplasticity. They are particularly effective in treating stroke, spinal cord injuries, and other neurological conditions. Neuro-robotic devices accounted for 45% of the market share in 2023. Their high functionality, precision, and ability to deliver personalized therapy made them a go-to choice in rehabilitation centers, especially in well-funded healthcare facilities that can accommodate these advanced technologies.
Brain-computer interfaces emerged as the fastest-growing segment throughout the forecast period. BCIs enable direct communication between the brain and external devices, bypassing damaged neural pathways to restore lost functions. They are being increasingly used in treating neurological conditions such as stroke, traumatic brain injury, and Parkinson’s disease. The rapid advancements in BCI technology, along with its expanding clinical applications in neurorehabilitation, are driving the growth of this segment.
By Application
Brain stroke was the dominant application in the neurorehabilitation market in 2023, accounting for around 35% of the market share. This is due to the high prevalence of stroke worldwide and the increasing focus on rehabilitation for recovery. Stroke patients require intensive rehabilitation therapies, particularly in motor function and cognitive recovery, where neurorehabilitation technologies like neuro-robotic devices and BCIs play a significant role in improving recovery outcomes.
Traumatic Brain Injury emerged as the fastest-growing application over the forecast period. The growing prevalence of TBI, especially in younger populations, military personnel, and athletes, combined with the increasing adoption of advanced neurorehabilitation techniques, is fueling this segment's growth. Technologies like neuro-robotic devices and BCIs are increasingly being used to enhance recovery outcomes, focusing on motor and cognitive rehabilitation for TBI patients.
North America held the largest share of the market, accounting for around 40% in 2023. This dominance is attributed to advanced healthcare systems, high adoption of cutting-edge technologies like neuro-robotic devices and brain-computer interfaces, and substantial investments in neurorehabilitation research and development. The United States, in particular, has a well-established market due to the increasing number of stroke, traumatic brain injury, and spinal cord injury cases, as well as the presence of key market players.
The Asia Pacific region is anticipated to be the fastest-growing neurorehabilitation market. This is driven by rising healthcare awareness, improving infrastructure, and an increase in the incidence of neurological disorders. Countries like China and India are witnessing an uptick in demand for neurorehabilitation services due to expanding healthcare access and growing investment in medical technology, making it the key growth region moving forward.
Need any customization research on Neurorehabilitation Market - Enquiry Now
InMotion ARM and InMotion Hand.
2. BioScience Managers Ltd. (Rex Bionics Ltd)
Rex Robot.
3. Bioventus (Bioness Inc.)
Ness H200, Ness L300.
4. DIH (Hocoma AG)
Lokomat, Armeo, Valedo.
5. Ekso Bionics Holdings, Inc.
EksoGT.
6. Eodyne
Various neurorehabilitation technologies.
7. Neofect
Various rehabilitation devices including smart rehabilitation systems.
8. Neuro Rehab VR
Virtual reality-based rehabilitation solutions.
9. Reha Technology AG
Robotic rehabilitation systems for physical and neurological recovery.
10. ReWalk Robotics Ltd.
ReWalk exoskeleton.
11. Abbott Laboratories
Neuromodulation therapies.
12. Helius Medical Technologies
Portable neurostimulation devices.
13. Medtronic Inc.
Deep brain stimulation (DBS) systems.
14. Hocoma AG
Lokomat, Armeo, Valedo (also listed under DIH).
15. Bionik Laboratories Corp.
InMotion ARM and InMotion Hand (also listed under Bionik Laboratories).
Recent Development
In Dec 2024, The Mondino Foundation partnered with Kemtai to launch a groundbreaking research initiative aimed at assisting Parkinson's patients with Pisa Syndrome. The project will utilize Kemtai CARE's advanced computer vision platform to help patients maintain their rehabilitation progress post-hospitalization, supporting ongoing recovery at home.
In September 2024, the Neuro-Optometric Rehabilitation Association appointed Barbara Barclay, a leader in eye-tracking technology and health tech, as its new Executive Director, effective October 1. Barclay's expertise will drive the organization's efforts to advance neurorehabilitation.
In Aug 2024, Strolll secured a USD 3 million partnership with the Cleveland Clinic to expand its augmented reality neurorehabilitation platform for Parkinson’s disease. Under the exclusive software license agreement, Cleveland Clinic will also become a shareholder in Strolll, helping extend prescribed AR rehab into patients' homes.
In March 2024, Trilife Hospital unveiled a state-of-the-art Neuro Rehabilitation and Sports Medicine Center to revolutionize outpatient care. Spanning 60,000 square feet, the new facility is one of the largest in the city and features the latest equipment and technology.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.95 billion |
| Market Size by 2032 | USD 6.18 billion |
| CAGR | CAGR of 13.68% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Neuro-Robotic Devices, Non-Invasive Stimulators, Brain-Computer Interfaces) • By Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, Others) • By End User (Rehabilitation Centers, Hospitals, Clinics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Bionik Laboratories Corp., BioScience Managers Ltd. (Rex Bionics Ltd), Bioventus (Bioness Inc.), DIH (Hocoma AG), Ekso Bionics Holdings, Inc., Eodyne, Neofect, Neuro Rehab VR, Reha Technology AG, ReWalk Robotics Ltd., Abbott Laboratories, Helius Medical Technologies, Medtronic Inc., and Hocoma AG |
| Key Drivers | • Advanced Neurotechnologies Driving Recovery • Rise of Outpatient and Home-Based Therapies |
| Restraints | • Challenges Hindering Growth in the Neurorehabilitation Market including High Costs, Limited Access, and Lack of Expertise |
Ans: The estimated compound annual growth rate is 13.68% during the forecast period for the Neurorehabilitation market.
Ans: The projected market value of the Neurorehabilitation market is estimated at USD 1.95 billion in 2023 and is expected to reach USD 6.18 billion by 2032.
Ans: Adopting cutting-edge technologies like brain-computer interfaces and non-invasive neurostimulation methods such as transcranial magnetic stimulation is significantly boosting the neurorehabilitation market.
Ans: High costs associated with advanced technologies like robotic-assisted systems, brain-computer interfaces, and virtual reality platforms are a primary restraint.
Ans: North America is the dominant region in the Neurorehabilitation market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Neurorehabilitation Market Segmentation, by Type
7.1 Chapter Overview
7.2 Neuro-Robotic Devices
7.2.1 Neuro-Robotic Devices Market Trends Analysis (2020-2032)
7.2.2 Neuro-Robotic Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Non-Invasive Stimulators
7.3.1 Non-Invasive Stimulators Market Trends Analysis (2020-2032)
7.3.2 Non-Invasive Stimulators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Brain-Computer Interfaces
7.4.1 Brain-Computer Interfaces Market Trends Analysis (2020-2032)
7.4.2 Brain-Computer Interfaces Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Neurorehabilitation Market Segmentation, by Application
8.1 Chapter Overview
8.2 Brain Stroke
8.2.1 Brain Stroke Market Trends Analysis (2020-2032)
8.2.2 Brain Stroke Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Parkinson's Disease
8.3.1 Parkinson's Disease Market Trends Analysis (2020-2032)
8.3.2 Parkinson's Disease Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Multiple Sclerosis
8.4.1 Multiple Sclerosis Market Trends Analysis (2020-2032)
8.4.2 Multiple Sclerosis Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Spinal Cord Injury
8.5.1 Spinal Cord Injury Market Trends Analysis (2020-2032)
8.5.2 Spinal Cord Injury Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Traumatic Brain Injury
8.6.1 Traumatic Brain Injury Market Trends Analysis (2020-2032)
8.6.2 Traumatic Brain Injury Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Cerebral Palsy
8.7.1 Cerebral Palsy Market Trends Analysis (2020-2032)
8.7.2 Cerebral Palsy Market Size Estimates and Forecasts to 2032 (USD Billion)
8.8 Others
8.8.1 Others Market Trends Analysis (2020-2032)
8.8.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Neurorehabilitation Market Segmentation, by End User
9.1 Chapter Overview
9.2 Rehabilitation Centers
9.2.1 Rehabilitation Centers Market Trends Analysis (2020-2032)
9.2.2 Rehabilitation Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Hospitals
9.3.1 Hospitals Market Trends Analysis (2020-2032)
9.3.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Clinics
9.4.1 Clinics Market Trends Analysis (2020-2032)
9.4.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 turkey
10.3.1.9.1 Turkey Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Neurorehabilitation Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Neurorehabilitation Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Neurorehabilitation Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Neurorehabilitation Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Bionik Laboratories Corp.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product / Services Offered
11.1.4 SWOT Analysis
11.2 BioScience Managers Ltd. (Rex Bionics Ltd)
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product / Services Offered
11.2.4 SWOT Analysis
11.3 Bioventus (Bioness Inc.)
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product / Services Offered
11.3.4 SWOT Analysis
11.4 DIH (Hocoma AG)
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product / Services Offered
11.4.4 SWOT Analysis
11.5 Ekso Bionics Holdings, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product / Services Offered
11.5.4 SWOT Analysis
11.6 Abbott Laboratories
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product / Services Offered
11.6.4 SWOT Analysis
11.7 Helius Medical Technologies
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product Types/ Services Offered
11.7.4 SWOT Analysis
11.8 Bionik Laboratories Corp.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product / Services Offered
11.8.4 SWOT Analysis
11.9 Hocoma AG
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product / Services Offered
11.9.4 SWOT Analysis
11.10 Medtronic Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product / Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Neuro-Robotic Devices
Non-Invasive Stimulators
Brain-Computer Interfaces
By Application
Brain Stroke
Parkinson's Disease
Traumatic Brain Injury
Cerebral Palsy
Others
By End User
Rehabilitation Centers
Hospitals
Clinics
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Teledentistry Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 6.03 billion by 2032, growing at a CAGR of 16.07% from 2024-2032.
The Transfer Membrane Market size was estimated at USD 402.91 million in 2023 and is expected to reach USD 603.95 million by 2032 with a growing CAGR of 4.6% during the forecast period of 2024-2032.
The Legionella Testing Market size was valued at USD 283.52 Million in 2023 & is estimated to reach USD 581.08 Million by 2032 and increase at a CAGR of 8.3% between 2024 and 2032.
The Medical Tourism Market Size was valued at USD 10.78 Billion in 2023, and is expected to reach USD 70.18 Billion by 2032, and grow at a CAGR of 24.52% over the forecast period 2024-2032.
The Deep Brain Stimulation (DBS) Devices Market Size was valued at USD 1.25 billion in 2023 and is witnessed to reach USD 3.10 billion by 2032 and grow at a CAGR of 11.12% over the forecast period 2024-2032.
The Sleep Apnea Devices Market Size was valued at USD 4.69 billion in 2023 and is projected to reach USD 7.82 billion by 2031 with a growing CAGR of 6.60% Over the Forecast Period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
